Skip to content

The effect of Botulinum toxin treatment on the activity level of patients with a spastic hemiparesis after stroke

The effect of Botulinum toxin treatment on the activity level of patients with a spastic hemiparesis after stroke - activity level of stroke patients after Botulinum toxine treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29937
Enrollment
20
Registered
2006-10-12
Start date
2006-09-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebro vascular accident stroke

Interventions

None listed

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age 18 - 65 years - at least 6 months post-injury - indication for injections of Botulinum toxin because of spastic gait

Exclusion criteria

Exclusion criteria: - simultaneously undergoing other treatments related to gait training - wheelchair dependent - having contractures on the lower limbs - serious cognitive impairments (not able to learn and/or train anything) - serious comorbidities related to mobility - having had injections of botulinum toxin less than 6 months ago

Design outcomes

Primary

MeasureTime frame
Activity level (measured by the ADL-monitor)

Secondary

MeasureTime frame
- activity level (measured by the SF-36) - walking ability (measured using instrumented gaitanalysis)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)